LDL - Lydall Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 CCL (2.3%) DOGEUSD (%) WKHS (12.9%) CUK (2.48%) CZR (1.89%) KSS (2.36%) MIDD (0.98%) MRO (-4.63%) AMZN (-1.62%) ASB (4.38%) BTCUSD (%) CLR (-3%) ETHUSD (%) FTI (-1.95%) HAL (2.19%) LB (-0.79%) LINKUSD (%) MGM (1.92%) MTZ (1.21%) PACW (1.53%) PBCT (1.96%) PLTR (-5.98%) PWR (0.27%) TRXC (0%) DQ (-9.93%)

LDL - Lydall

$38.55 0.82[2.18%]

15 mins delayed data

People also watch : AWR | BWA | KOOL | UFI | DAN | QTWWQ

+Watchlist

Analyst Ratings | Earnings

Previous Close	$37.73	Open	$37.93
Volume	95K	Market Cap	336.07M
Yield		Last Dividend

Day

52 Week

Membrane Microfiltration Market 2028 Siz...	02/25/21
This Future Market Insights (FMI) report examines the ???Global Membrane Microfiltration Market??? for the period 2018???2028. The primary objective o...

Lydall's Earnings: A Preview	02/22/21
Lydall (NYSE:LDL) unveils its next round of earnings this Tuesday, February 23. Get prepared with Benzinga's ultimate preview for Lydall's Q4 ???

Prevail Therapeutics, Oncocyte, Baidu: 5...	12/15/20
Prevail Therapeutics, Oncocyte, Lydall, Baidu and RealReal are five of the top gainers for Tuesday.

Thinking about buying stock in OncoCyte,...	12/15/20
NEW YORK, Dec. 15, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OCX, FCEL, EVLO, LDL, and PRVL. To see how InvestorsOb...

Lydall Stock Could Correct Before Resumi...	12/15/20
Lydall Stock Could Correct Before Resuming Their Rally???LDL

GROUPE LDLC : R??SULTATS SEMESTRIELS 202...	12/03/20
CHIFFRE D'AFFAIRES CONSOLID?? DE 314,3 M??? AU 1ER SEMESTRE, EN HAUSSE DE 41,6% (+21,0% ?? P??RIM??TRE CONSTANT) PROGRESSION DE 2,9 PTS DU TAUX DE MAR...

Lydall Earnings and Growth Analysis : St...	10/27/20
Lydall announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by???

Global Nonwoven Fabrics for Filtration M...	10/13/20
Global Nonwoven Fabrics for Filtration Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 aims to define, describe, and ana...

Lydall Breaks Ground on New Filtration C...	07/31/20
MANCHESTER, Conn., July 31, 2020 -- Lydall, Inc. , a leading U.S. manufacturer of value-added engineered materials and specialty filtration solutions ...

Lydall EPS beats by $0.28, misses on rev...	07/28/20
Lydall (NYSE:LDL): Q2 Non-GAAP EPS of -$0.27 beats by $0.28; GAAP EPS of -$0.34 beats by $0.43. Revenue of $146.16M (-33.8% Y/Y) misses by $12.49M. Pr...

Lydall Announces Financial Results for t...	07/28/20
MANCHESTER, CT, July 28, 2020 (GLOBE NEWSWIRE) -- LYDALL, INC. (NYSE: LDL) today announced financial results for the second quarter ended June 30, 202...

GROUPE LDLC : ACTIVIT?? TR??S DYNAMIQUE ...	07/23/20
23/07/2020 17:45:00 - CHIFFRE D'AFFAIRES CONSOLID?? EN PROGRESSION DE 43,7% ?? 149,1 M??? (+23,2% ?? P??RIM??TRE CONSTANT) FORTE CROISSANCE DES ACTIVI...

Groupe LDLC : PRESENTATION FULL YEAR RES...	07/20/20
No. 1 in France Strong brand recognition in the education market 16 branches including 11 Apple Premium Reseller stores ??? \| July 20, 2020

GROUPE LDLC : FORTE PROGRESSION DES R??S...	06/18/20
18/06/2020 17:45:00 - ACTIVIT??S BTOC EN CROISSANCE AU 2ND SEMESTRE 2019-2020 AM??LIORATION STRUCTURELLE DE LA MARGE BRUTE ?? 19,3% (VS. 17,0% EN N-1)...

ANALYST RATINGS

1 analyst ratings (Last 3 months)

100.00 %

Strong Buy + Buy

Price Target (PT)

EARNINGS

Date	2021-02-23 (AMC)	Est. (EPS/Rev.)	$0.07/ 197.05M
Actual (EPS/Rev.)	$0.07/ $210.27 M	EPS (TTM)	0

TRADERS TRACKING $LDL

No traders tracking are currently recommending this stock

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.